Suraksha Diagnostic IPO

Dominant position in Eastern India: Suraksha Diagnostic is the largest diagnostic chain with a dominant position in Eastern India. With a wide network, it is well positioned to leverage high growth opportunity for organized diagnostic chains in the fragmented diagnostic services markets in Eastern and North-Eastern India.

One-stop solution offering : Integrated diagnostics provider with one-stop solution offering pathology and radiology testing, and medical consultation services. Compay offers a comprehensive range of 2,300+ tests that cover a range of specialties and disciplines.

Developed infrastructure: Company's flagship central reference laboratory in Kolkata is spread over an area of 40,000 square feet, houses a fully automated AI enabled robotic track, liquid chromatography, cytogenetics, and next-gen sequencing capabilities.

High brand recall : Company has built a trusted, high quality and reliable brand of choice over the last three decades, evidenced by high repeat rate of over 49%.

Geographic concentration: While they have presence across 12 cities and towns in India across the states of West Bengal, Bihar, Assam, and Meghalaya, a significant portion of operations are concentrated in West Bengal. Any loss of market share in the region can impact business.

New technologies: Failure to introduce new tests, services and technologies or acquire new or improved equipment could adversely affect business.

High competition: With several diagnostic companies present in the market, the diagnostics industry in India is highly competitive and competitors include other well known diagnostic chains, such as, Vijaya Diagnostic Centre Limited, Agilus Diagnostics Limited, Dr. Lal Pathlabs Limited, Metropolis Healthcare Limited and Thyrocare Technologies Limited.